Trials / Completed
CompletedNCT02365636
A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpetic Neuralgia (PHN)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (4% and 8% w/w Ointment) in Patients With Postherpetic Neuralgia.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a study to evaluate the safety and efficacy of 4% and 8% w/w TV 45070 ointment compared with placebo ointment applied topically and twice daily to the area of PHN pain for 4 weeks in patients with PHN
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TV-45070 | TV-45070 is an ointment applied topically twice daily to area of pain. |
| DRUG | Placebo | The matching placebo ointment contained only the excipients of the active treatment; also applied topically twice daily to area of pain. |
Timeline
- Start date
- 2015-02-26
- Primary completion
- 2017-05-09
- Completion
- 2017-05-09
- First posted
- 2015-02-19
- Last updated
- 2021-11-09
- Results posted
- 2018-10-23
Locations
77 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT02365636. Inclusion in this directory is not an endorsement.